PeptiDex
Peptide Research Index
Research-backed
Peptide Research Index
⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use
⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use
Also: Body Protection Compound-157, PL 14736
🛡ï¸Body Protective CompoundPromotes angiogenesis, collagen deposition, and modulates growth factors for accelerated healing. Acts on multiple repair pathways simultaneously including tendon, ligament, muscle, gut lining, and nerve tissue.
Comprehensive review demonstrating potent tendon, ligament, and gut healing effects across multiple preclinical models.
preclinicalRobert et al. demonstrate BPC-157 heals GI ulcers, fistulas, and inflammatory bowel lesions in rats via cytoprotective pathways. Published in Current Pharmaceutical Design.
preclinicalStaresinic et al. show BPC-157 accelerates healing of transected Achilles tendons, enhancing tendon fibroblast outgrowth and survival via FAK-paxillin signaling.
preclinicalSystematic review of 35 preclinical and 1 clinical study (1993–2024). BPC-157 promotes angiogenesis, collagen synthesis, and reduces inflammatory cytokines across muscle, tendon, ligament, and bone injury models.
preclinicalPreclinical evidence showing BPC-157 counteracts stroke-induced neuronal damage and improves functional recovery after spinal cord compression in rats.
preclinicalDemonstrates BPC-157's strong angiogenic potential via VEGFR2-Akt-eNOS pathway activation, endothelium protection, and reversal of thrombus formation.
preclinicalExcellent research safety profile; commonly used for recovery. Not FDA-approved. Most evidence from animal models. FDA restricted use in compounded medications in Sept 2023.
⚠️ For educational purposes only. Not medical advice. Consult a healthcare professional before using any peptide.
Often run 250mcg 2x/day for injuries. Can be injected near injury site.
Last updated: 2026-01 · Laws change frequently. Verify current status in your jurisdiction.
Week 1
Reduced pain/inflammation at injury site; improved GI comfort if used for gut healing
Weeks 2-4
Noticeable mobility improvement; significant reduction in injury-site swelling
Month 2-3
Substantial tissue remodeling; most acute injuries showing measurable repair
Long-term
Full tendon/ligament functional recovery in most preclinical models; sustained GI remission
| Side Effect | Incidence | Severity |
|---|---|---|
Lightheadedness | ~5% of users | mild |
Nausea (especially oral route) | ~3-5% of users | mild |
Vivid dreams | ~5% of users | mild |
Euphoria / mood lift Often not considered adverse; may reflect CNS activity | ~8% of users | mild |
Incidence rates sourced from published clinical trial data where available; otherwise based on community research observations.
Strengthen and modulate immune function for enhanced pathogen defense
Repair and protect the gastrointestinal lining and reduce GI inflammation
Weekly Peptide Research
New studies · vendor alerts · protocol tips
No spam. Unsubscribe anytime. Research use only.